Related Experiment Video

Updated: Apr 5, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.6K

Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems

Emilia Licarete1,2, Alina Sesarman1,2, Manuela Banciu1,2

  • 1a Department of Molecular Biology and Biotechnology, Faculty of Biology and Geology , Babes-Bolyai University , Cluj-Napoca , Romania and.

Journal of Microencapsulation
|August 25, 2015
PubMed

Insights

Statins exhibit anti-tumour properties through pleiotropic effects at high doses, inhibiting cancer growth. Targeted delivery systems are crucial for managing side effects and enhancing statin application in oncology.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Statins are primarily used for cholesterol reduction.
  • High-concentration statins demonstrate significant anti-tumour activity.
  • This activity stems from inhibiting mevalonate synthesis, impacting cancer cell processes.

Purpose of the Study:

  • To review the pleiotropic anti-cancer effects of statins.
  • To explore the mechanisms of statin-mediated tumour growth inhibition.
  • To discuss targeted delivery systems for statins in cancer therapy.

Main Methods:

  • Literature review of statin's role in oncology.
  • Analysis of statin's pleiotropic effects on cancer pathways.
  • Overview of current targeted delivery systems for statins.

Main Results:

  • Statins possess anti-proliferative, pro-apoptotic, anti-angiogenic, anti-inflammatory, and anti-metastatic properties.
  • Modulation of intra-tumour oxidative stress is another key effect.
  • High-dose statin use is limited by severe side effects.

Conclusions:

  • Statins have multifaceted anti-cancer actions via mevalonate pathway inhibition.
  • Targeted statin delivery is essential for safe and effective oncological use.
  • Further research into targeted delivery systems is warranted for clinical application.
Keywords:
Cancerpleiotropic actionsstatinstargeted-deliverytoxicity

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K
Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.6K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
112
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
113